Regulatory Approvals

FDA clears blood test to aid evaluation for Alzheimer’s disease

By

Regulatory Approvals — FDA clears blood test to aid evaluation for Alzheimer’s disease  WashU Medicine

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 21, 2026.

By

Related Post

Regulatory Approvals

FDA Clears First-of-Its-Kind Alzheimer Blood Test for Adults With Cognitive Symptoms

Regulatory Approvals

FDA Clears PrecivityAD2 Alzheimer Blood Test for Symptomatic Patients 40 and Older

Regulatory Approvals

Ultragenyx Receives Accelerated FDA Approval For Metabolic Gene Therapy

Financial News For All

Mergers & Acquisitions

UC Merced Celebrates Permanent Acquisition of ‘Four Seasons of Yosemite’ Murals

Mergers & Acquisitions

Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug

Labor

Encore Boston Harbor workers vote to authorize strike amid contract negotiations – Boston News, Weather, Sports

Labor

Boeing engineers, technical workers reject contracts, could strike after fall deadline